Association of the COVID-19 Pandemic with HbA1c Testing and Complication Screening in Patients with Diabetes Mellitus
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to identify the association between coronavirus disease 2019 (COVID-19) transmission levels and undergoing glycated hemoglobin (HbA1c) test and complication screenings among patients with diabetes mellitus. Materials and Methods: We included a total of 3601 diabetes patients’ data from the 2020 Korean Community Health Survey to analyze the extent of the HbA1c testing and fundus examination, and 3592 diabetes patients’ data to analyze kidney disease screening. COVID-19 transmission levels were classified into low transmission (Busan, Gwangju, Daejeon, Ulsan, and Sejong) and high transmission (Daegu, where the first large outbreak of COVID-19 occurred in Korea). Multiple logistic regression was used to obtain adjusted odds ratio (ORs) and 95% confidence interval (CI) to determine the association of COVID-19 transmission levels with undergoing HbA1c testing and diabetes complication screening. Results: The proportion of subjects who underwent complication screening of diabetes was lower in the high transmission region (low transmission vs. high transmission: 42.3% vs. 38.0% for fundus examination; 48.9% vs. 45.7% for kidney disease screening). A high COVID-19 transmission level was associated with decreased odds of undergoing fundus examination (OR, 0.82; 95% CI, 0.69–0.98) and kidney disease screening (OR, 0.76; 95% CI, 0.63–0.91). However, COVID-19 transmission levels were not significantly associated with undergoing HbA1c testing. Conclusion: A high level of COVID-19 transmission was associated with a decrease in undergoing fundus examination and kidney disease screening. To fully realize the potential benefit of diabetes complication screenings, further effort is required to identify and address challenges to obtaining these screenings, especially in outbreak regions.
Abstract
Purpose: This study aimed to identify the association between coronavirus disease 2019 (COVID-19) transmission levels and undergoing glycated hemoglobin (HbA1c) test and complication screenings among patients with diabetes mellitus. Materials and Methods: We included a total of 3601 diabetes patients’ data from the 2020 Korean Community Health Survey to analyze the extent of the HbA1c testing and fundus examination, and 3592 diabetes patients’ data to analyze kidney disease screening. COVID-19 transmission levels were classified into low transmission (Busan, Gwangju, Daejeon, Ulsan, and Sejong) and high transmission (Daegu, where the first large outbreak of COVID-19 occurred in Korea). Multiple logistic regression was used to obtain adjusted odds ratio (ORs) and 95% confidence interval (CI) to determine the association of COVID-19 transmission levels with undergoing HbA1c testing and diabetes complication screening. Results: The proportion of subjects who underwent complication screening of diabetes was lower in the high transmission region (low transmission vs. high transmission: 42.3% vs. 38.0% for fundus examination; 48.9% vs. 45.7% for kidney disease screening). A high COVID-19 transmission level was associated with decreased odds of undergoing fundus examination (OR, 0.82; 95% CI, 0.69–0.98) and kidney disease screening (OR, 0.76; 95% CI, 0.63–0.91). However, COVID-19 transmission levels were not significantly associated with undergoing HbA1c testing. Conclusion: A high level of COVID-19 transmission was associated with a decrease in undergoing fundus examination and kidney disease screening. To fully realize the potential benefit of diabetes complication screenings, further effort is required to identify and address challenges to obtaining these screenings, especially in outbreak regions.
참고문헌 (40)
- Fonseca VA, "Impact of a natural disaster on diabetes : exacerbation of disparities and long-term consequences", Diabetes Care, 32, pp.1632~1638 (2009)
- Huang HH, "Declining emergency department visits and costs during the severe acute respiratory syndrome(SARS)outbreak", J Formos Med Assoc, 105, pp.31~37 (2006)
- Lee SY, "Impact of the 2015 Middle East respiratory syndrome outbreak on emergency care utilization and mortality in South Korea", Yonsei Med J, 60, pp.796~803 (2019)
- Choudhary R, "Management of cardiovascular emergencies during the COVID-19 pandemic", Emerg Med J, 37, pp.778~780 (2020)
- Rudnicki Y, "The impact of COVID-19 pandemic lockdown on the incidence and outcome of complicated appendicitis", Surg Endosc, 36, pp.3460~3466 (2022)
- Laing S, "Estimated impact of COVID-19 on preventive care service delivery : an observational cohort study", BMC Health Serv Res, 21, pp.1107~ (2021)
- Vanni G, "Lockdown of breast cancer screening for COVID-19 : possible scenario", In Vivo, 34, pp.3047~3053 (2020)
- Walker MJ, "Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada : a provincial, population-based study", Prev Med, 151, pp.106586~ (2021)
- Williams R, "Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic : a retrospective cohort study", Lancet Public Health, 5, pp.e543~e550 (2020)
- Levene LS, "Pandemic threatens primary care for long term conditions", BMJ, 371, pp.m3793~ (2020)
- Maringe C, "The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK : a national, populationbased, modelling study", Lancet Oncol, 21, pp.1023~1034 (2020)
- Mohseni M, "Challenges of routine diabetes care during COVID-19 era : a systematic search and narrative review", Prim Care Diabetes, 15, pp.918~922 (2021)
- Rabbone I, "Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children?", Diabetes Care, 43, pp.2870~2872 (2020)
- Dz · ygało K, "Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown : an observational cohort study", Pediatr Endocrinol Diabetes Metab, 26, pp.167~175 (2020)
- Ghosal S, "Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications : a simulation model using multivariate regression analysis", Diabetes Metab Syndr, 14, pp.319~323 (2020)
- Karatas S, "Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people", Prim Care Diabetes, 15, pp.424~427 (2021)
- Carr MJ, "Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes : a UK-wide cohort study involving 618 161 people in primary care", BMJ Qual Saf, 31, pp.503~514 (2022)
- Kang YW, "Korea community health survey data profiles", Osong Public Health Res Perspect, 6, pp.211~217 (2015)
- "Resident registration population"[URL]
- "Regional income statistics"[URL]
- Kim SW, "A brief telephone severity scoring system and therapeutic living centers solved acute hospital-bed shortage during the COVID-19 outbreak in Daegu, Korea", J Korean Med Sci, 35, pp.e152~ (2020)
- Seong H, "Comparison of the second and third waves of the COVID-19 pandemic in South Korea : importance of early public health intervention", Int J Infect Dis, 104, pp.742~745 (2021)
- Caballero AE, "COVID-19 in people living with diabetes : an international consensus", J Diabetes Complications, 34, pp.107671~ (2020)
- Barone MTU, "COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis", Diabetes Res Clin Pract, 171, pp.108587~ (2021)
- Sherman BW, "The association of smoking with medical treatment adherence in the workforce of a large employer", Patient Prefer Adherence, 8, pp.477~486 (2014)
- Merrick EL, "Unhealthy drinking patterns and receipt of preventive medical services by older adults", J Gen Intern Med, 23, pp.1741~1748 (2008)
- Kang SW, "Physical activity and health services utilization and costs among U. S. adults", Prev Med, 96, pp.101~105 (2017)
- Axon DR, "Patterns of healthcare expenditures among older United States adults with pain and different perceived health status", Healthcare(Basel), 9, pp.1327~ (2021)
- Lurie N, "The role of telehealth in the medical response to disasters", JAMA Intern Med, 178, pp.745~746 (2018)
- Hangaard S, "The effectiveness of telemedicine solutions for the management of type 2 diabetes : a systematic review, meta-analysis, and meta-regression", J Diabetes Sci Technol, 17, pp.794~825 (2023)
- Faruque LI, "Effect of telemedicine on glycated hemoglobin in diabetes : a systematic review and meta-analysis of randomized trials", CMAJ, 189, pp.E341~E364 (2017)
- Tchero H, "Clinical effectiveness of telemedicine in diabetes mellitus : a meta-analysis of 42 randomized controlled trials", Telemed J E Health, 25, pp.569~583 (2019)
- Onishi Y, "Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan", J Diabetes Investig, 13, pp.386~390 (2022)
- Predieri B, "Glycemic control improvement in Italian children and adolescents with type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic", Front Endocrinol(Lausanne), 11, pp.595735~ (2020)
- Galiero R, "The importance of telemedicine during COVID-19 pandemic : a focus on diabetic retinopathy", J Diabetes Res, 2020, pp.9036847~ (2020)
- Zhang W, "Effect of telemedicine on quality of care in patients with coexisting hypertension and diabetes : a systematic review and meta-analysis", Telemed J E Health, 27, pp.603~614 (2021)
- Hazenberg CEVB, "Telehealth and telemedicine applications for the diabetic foot : a systematic review", Diabetes Metab Res Rev, 36, pp.e3247~ (2020)
- Garnett ER, "Pandemic-associated trends in measurement of HbA1c in children with diabetes mellitus and validation of dried blood spot as an alternative sample matrix", Ann Clin Lab Sci, 51, pp.535~539 (2021)
- Roberts AJ, "Adapting to telemedicine in the COVID-19 era : feasibility of dried blood spot testing for hemoglobin A1c", Diabetes Metab Syndr, 15, pp.433~437 (2021)
